Wasatch Advisors’s DNA X Inc SONM Stock Holding History

Wasatch Advisors’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-305	Closed	-$1.61M	–	253
2019 Q3	$1.61M	Sell	305 -49	-14%	-$752K	0.02%	231
2019 Q2	$8.11M	Buy	+354	New	+$8.98M	0.08%	144

Other funds holding SONM

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return

Wasatch Advisors's SONM Position: Q4 2019 in Review

Wasatch Advisors sold out of DNA X Inc (SONM) in Q4 2019, closing a stake of 305 shares — an estimated $1.61M sold.

Wasatch Advisors first reported a position in SONM in Q2 2019 and held it in 2 quarters. The position peaked at $8.11M in Q2 2019. 40 funds tracked by Wall St. Rank hold SONM as of Q4 2019.

Wasatch Advisors reported no remaining DNA X Inc position as of Q4 2019 after selling out during the quarter.
Wasatch Advisors sold 305 DNA X Inc shares in Q4 2019, an estimated $1.61M.
Wasatch Advisors first reported a position in DNA X Inc in Q2 2019 and held it in 2 quarters.
Wasatch Advisors's DNA X Inc position peaked at $8.11M in Q2 2019.
40 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2019.

Based on Wasatch Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.